Marketing-authorisation holder · Canada
Qed Therapeutics, Inc.
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| TRUSELTIQ50 mg / dose · Capsule | Infigratinib | Canada | Cancelled | |
| TRUSELTIQ125 mg / dose · Capsule | Infigratinib | Canada | Cancelled | |
| TRUSELTIQ100 mg / dose · Capsule | Infigratinib | Canada | Cancelled | |
| TRUSELTIQ75 mg / dose · Capsule | Infigratinib | Canada | Cancelled |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 4 | 0 | 4 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.